文献速递甲状腺疾病性腺与生殖内分泌

甲状腺自身免疫不孕女性中卵胞浆内单精子注射与体外受精的比较

Intracytoplasmic Sperm Injection Versus In vitro Fertilization in Infertile Women with Thyroid Autoimmunity.
PubMed 文献 · Thyroid · 2024-05-02

这项回顾性队列研究纳入2019年1月至2021年2月在北京大学第三医院生殖中心首次接受IVF/ICSI及胚胎移植的不孕女性,比较甲状腺自身免疫(TAI)阳性与阴性女性中ICSI与IVF的生殖结局。TAI阳性女性中,ICSI组的累积活产率、临床妊娠率和活产率均显著低于IVF组,但受精率较高。作者认为TAI女性使用ICSI未带来更好的辅助生殖结局,需进一步前瞻性临床试验证实。

核心结论

  • 在TAI女性中,ICSI与IVF相比未带来更好的辅助生殖结局,累积活产率、临床妊娠率和活产率均显著低于IVF组。
  • 作者指出需要进一步的前瞻性临床试验来证实这些发现。

研究设计与样本

  • 回顾性队列研究,纳入2019年1月至2021年2月期间转诊至北京大学第三医院生殖中心接受首次IVF/ICSI及胚胎移植治疗周期的不孕女性。
  • TAI阳性女性中2171例行IVF、743例行ICSI;TAI阴性女性中8702例行IVF、2668例行ICSI。
  • 主要结局为从启动刺激周期起的累积活产率,次要结局包括受精率、首次胚胎移植周期后的临床妊娠率和活产率。
  • 采用多因素logistic回归分析校正相关混杂因素。

主要发现

  • ICSI组受精率显著高于IVF组:TAI阳性IVF组中位数0.6(四分位距0.5-0.8)vs TAI阳性ICSI组0.7(0.5-0.8)vs TAI阴性IVF组0.6(0.5-0.8)vs TAI阴性ICSI组0.7(0.5-0.8),p<0.001。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Background: It has been reported that intracytoplasmic sperm injection (ICSI) may be the preferred fertilization method for women with thyroid autoimmunity (TAI) seeking assisted reproduction. We compared the reproductive outcomes of women with TAI who were treated with ICSI compared with in vitro fertilization (IVF). Methods: In this retrospective cohort study, we included women with infertility who were referred to the Reproductive Centre of Peking University Third Hospital for their first IVF/ICSI and embryo transfer (ET) treatment cycle from January 2019 to February 2021. In total, 2171 and 743 women with TAI underwent IVF and ICSI, respectively, while 8702 and 2668 women without TAI underwent IVF and ICSI, respectively. We examined the cumulative live birth rate (primary outcome) from the initiated stimulative cycle as well as the secondary outcomes of fertilization rate, rates of clinical pregnancy, and live birth after the first ET cycle. We compared the reproductive outcomes of women treated with IVF and ICSI according to TAI status. Multivariable logistic regression analyses were performed to adjust for relevant confounders. Results: Women who underwent ICSI had significantly higher fertilization rates than those who underwent IVF (median [interquartile range]: 0.6 [0.5-0.8] in the TAI-positive and IVF group vs. 0.7 [0.5-0.8] in the TAI-positive and ICSI group vs. 0.6 [0.5-0.8] the TAI-negative and IVF group vs. 0.7 [0.5-0.8] in the TAI-negative and ICSI group, p < 0.001). However, the rates of cumulative live births, clinical pregnancies, and live births were significantly lower among women with TAI who underwent ICSI than those who underwent IVF (cumulative live birth: 51.8% vs. 47%, adjusted odds ratio [aOR]: 0.80 [confidence interval, CI: 0.67-0.97]; clinical pregnancy: 43.0% vs. 38.8%, aOR: 0.81 [CI: 0.67-0.97]; live birth: 36.2% vs. 32.4%, aOR: 0.81 [CI: 0.66-0.98]). Conclusion: We observed that the use of ICSI in women with TAI was not associated with better assisted reproductive outcomes compared with IVF. Further prospective clinical trials are needed to confirm our findings.

来源:Thyroid,查看原文。版权归原作者所有。

引用

  1. Huang N, Chen L, Yan Z, et al. Intracytoplasmic Sperm Injection Versus In vitro Fertilization in Infertile Women with Thyroid Autoimmunity. Thyroid. 2024. PMID: 38623805. doi:10.1089/thy.2023.0676

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。